XPEL Inc XPEL Retreats 258 as Selling Pressure Mounts Near Key Support Canadian Biotech Stocks Under the Spotlight for 2026 KLAC Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower Elon Musks Bitcoin Stakes in Hypothetical TeslaSpaceX Merger A Potential Crypto Powerhouse